City

Kampala (1)

Lagos (1)

Odense C (1)

Portland (1)

Condition

Endomyocardial Fibrosis (3)

Acquired Heart Disease (1)

Aortic Valve Stenosis (1)

Congenital Heart Disease (1)

Heart Failure (1)

Rheumatic Fever (1)

Rheumatic Heart Disease (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Human Genome Research Institute (NHGRI) (1)

Odense University Hospital (1)

Oregon Health and Science University (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

Oregon Clinical and Translational Research Institute (1)

Intervention

placebo (1)

spironolactone 25mg (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Observational (2)

Interventional (1)

endomyocardial fibrosis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

The Genetic Basis of Acquired Heart Disease in Africa

Completed

Rheumatic Heart Disease
+3 more

Lagos, Nigeria
+1 more

Feb 12, 2020

Congenital Heart Disease, Heart Failure, Endomyocardial Fibrosis Trial in Portland (Spironolactone 25mg, Placebo)

Completed

Has Results

Congenital Heart Disease
+2 more

Spironolactone 25mg
Placebo

Portland, Oregon

Oregon Health & Science University

Jul 30, 2019

Assessment of Myocardial Fibrosis in Aortic STenosis

Completed

Endomyocardial Fibrosis
Aortic Valve Stenosis

Odense C, Denmark

Odense University Hospital

Apr 3, 2017